Neurocysticercosis is the most frequent parasitosis of the central ner
vous system in the world Due to the extension of the pandemy, and the
importance of the migrations from endemic countries, this parasitosis
is being diagnosed with increasing frequency in France. Epilepsy is th
e main revealing symptom. However, in endemic countries, neurocysticer
cosis should be suspected in patients with any neurological sign. Diag
nosis is based upon imaging procedures (computed tomography and magnet
ic resonance imaging) and serology (Elisa and Western blot). The evolu
tion is highly variable, from complete latency to severe encephalopath
y with psychomotor regression. Praziquantel and albendazole are the ma
in therapeutic agents. Although corticosteroids are usually very effec
tive on symptoms of the acute phase of the disease, their place in the
treatment remains to be clarified Racemic and ventricular forms of th
e disease usually need neurosurgery. In endemic regions, the diminutio
n of the frequency of the disease relies upon prevention through healt
h education compaigns, pending the achievement of an efficient vaccine
.